Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 14, Issue 6
|
pp. 2868–2879
TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types
Back to article
Figure 4
(4 of 4)
−
100%
+
Figure 4.
(
A
) Gene ontology (GO) and (
B
) Kyoto encyclopedia of gene and genomes (KEGG) pathway analysis of different expression mRNAs between TP53
MUT
BRAF
WT
and BRAF
MUT
TP53
WT
.